Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New models of kidney cancer developed in U.S.

July 6, 2012

Health Canada approves Jakavi for treatment of patients with myelofibrosis

July 6, 2012

Debio-0932 shows promising activity in patients with advanced solid tumors

July 6, 2012

Epizyme synthesizes novel DOT1-like protein inhibitors

July 6, 2012

Roche divulges novel Mdm2/p53 interaction inhibitors

July 6, 2012

Phase I/Ib trial evaluates AUY-922 alone and with bortezomib

July 6, 2012

Encouraging phase II results presented on PD-0332991

July 6, 2012

EXPAND trial in advanced gastric cancer does not meet primary endpoint

July 5, 2012

SB-485232/PLD combination shows acceptable safety in ovarian cancer

July 5, 2012

Maximum tolerated dose of NKP-1339 determined in first-in-human trial

July 5, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...